Editas Medicine
EDIT
EDIT
305 hedge funds and large institutions have $1.35B invested in Editas Medicine in 2021 Q4 according to their latest regulatory filings, with 54 funds opening new positions, 84 increasing their positions, 91 reducing their positions, and 65 closing their positions.
New
Increased
Maintained
Reduced
Closed
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
38% less capital invested
Capital invested by funds: $2.17B → $1.35B (-$814M)
53% less call options, than puts
Call options by funds: $23.8M | Put options by funds: $50.7M
Holders
305
Holding in Top 10
–
Calls
$23.8M
Puts
$50.7M
Top Buyers
| 1 | +$29.6M | |
| 2 | +$25.9M | |
| 3 | +$15.5M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$10.3M |
| 5 |
Two Sigma Advisers
New York
|
+$9.2M |
Top Sellers
| 1 | -$55.2M | |
| 2 | -$42.5M | |
| 3 | -$42.1M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$29.1M |
| 5 |
Goldman Sachs
New York
|
-$10.7M |